Cargando…
Treatment as prevention for hepatitis C virus in the Middle East and North Africa: a modeling study
BACKGROUND: Direct-acting antivirals opened an opportunity for eliminating hepatitis C virus (HCV) infection in the Middle East and North Africa (MENA), the region most affected by HCV infection. Impact of HCV treatment as prevention (HCV-TasP) was investigated in 19 MENA countries. METHODS: An age-...
Autores principales: | Ayoub, Houssein H., Mahmud, Sarwat, Chemaitelly, Hiam, Abu-Raddad, Laith J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374017/ https://www.ncbi.nlm.nih.gov/pubmed/37521971 http://dx.doi.org/10.3389/fpubh.2023.1187786 |
Ejemplares similares
-
Key associations for hepatitis C virus genotypes in the Middle East and North Africa
por: Mahmud, Sarwat, et al.
Publicado: (2019) -
Hepatitis C Virus Infection in Populations With Liver‐Related Diseases in the Middle East and North Africa
por: Mahmud, Sarwat, et al.
Publicado: (2020) -
Hepatitis C virus genotypes in the Middle East and North Africa: Distribution, diversity, and patterns
por: Mahmud, Sarwat, et al.
Publicado: (2017) -
Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses
por: Mahmud, Sarwat, et al.
Publicado: (2022) -
Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions
por: Harfouche, Manale, et al.
Publicado: (2017)